Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis
CompletedOBSERVATIONAL
Enrollment
21
Participants
Timeline
Start Date
August 31, 2014
Primary Completion Date
October 14, 2018
Study Completion Date
October 16, 2018
Conditions
ALS
Trial Locations (1)
27599
UNC Neurology ALS clinic, Chapel Hill
All Listed Sponsors
lead
University of North Carolina, Chapel Hill
OTHER
NCT02228915 - Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter